The association between BCL10 (BCL10 Immune Signaling Adaptor) and Mesothelioma, Malignant is well established and manually curated, with its 3 contributing sources — 2 of them expert-curated — recording a known molecular basis, pathogenic variants, and a susceptibility locus.
Sources3
Clinical variants3
Symptoms27
Compounds0
Trials0
Publications6
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.